 | • レポートコード：QY2108PAL3841 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は薬剤溶出インプラントの世界市場の現状について調査・分析し、2027年までの市場を予測しました。薬剤溶出インプラントの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ラパマイシン溶出性インプラント、パクリタキセル溶出性インプラント、エベロリムス溶出性インプラント、その他）、用途別市場規模（病院、クリニック、外来外科センター、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・薬剤溶出インプラントの世界市場概要 ・メーカー別の競争状況、市場シェア ・薬剤溶出インプラントの種類別市場規模：ラパマイシン溶出性インプラント、パクリタキセル溶出性インプラント、エベロリムス溶出性インプラント、その他 ・薬剤溶出インプラントの用途別市場規模：病院、クリニック、外来外科センター、その他 ・北米の薬剤溶出インプラント市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの薬剤溶出インプラント市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの薬剤溶出インプラント市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の薬剤溶出インプラント市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの薬剤溶出インプラント市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Boston Scientific、Medtronic、Abbott、Lepu Medical、B. Braun Melsungen、MicroPort Scientific、Cook Medical、Terumo、Biosensors International、Balton、AlviMedica Medical Technologies、Biotronik、Shandong JW Medical、Sino Medical、Beijing AMSINO ・薬剤溶出インプラントのバリューチェーン・販売チャネル分析 ・薬剤溶出インプラントの世界市場動向 |
Market Analysis and Insights: Global Drug Eluting Implant Market
The global Drug Eluting Implant market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Drug Eluting Implant Scope and Segment
Drug Eluting Implant market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Implant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Rapamycin Eluting Implant
Paclitaxel Eluting Implant
Everolimus Eluting Implant
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Company
Boston Scientific
Medtronic
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik
Shandong JW Medical
Sino Medical
Beijing AMSINO
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Drug Eluting Implant Product Introduction
1.2 Market by Type
1.2.1 Global Drug Eluting Implant Market Size Growth Rate by Type
1.2.2 Rapamycin Eluting Implant
1.2.3 Paclitaxel Eluting Implant
1.2.4 Everolimus Eluting Implant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Eluting Implant Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Eluting Implant Sales Estimates and Forecasts 2016-2027
2.2 Global Drug Eluting Implant Revenue Estimates and Forecasts 2016-2027
2.3 Global Drug Eluting Implant Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Drug Eluting Implant Regions by Sales
2.4.1 Global Top Drug Eluting Implant Regions by Sales (2016-2021)
2.4.2 Global Top Drug Eluting Implant Regions by Sales (2022-2027)
2.5 Global Top Drug Eluting Implant Regions by Revenue
2.5.1 Global Top Drug Eluting Implant Regions by Revenue (2016-2021)
2.5.2 Global Top Drug Eluting Implant Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Eluting Implant Sales by Manufacturers
3.1.1 Global Top Drug Eluting Implant Manufacturers by Sales (2016-2021)
3.1.2 Global Top Drug Eluting Implant Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Drug Eluting Implant Sales in 2020
3.2 Global Drug Eluting Implant Revenue by Manufacturers
3.2.1 Global Top Drug Eluting Implant Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Drug Eluting Implant Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Drug Eluting Implant Revenue in 2020
3.3 Global Drug Eluting Implant Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Eluting Implant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Eluting Implant Sales by Type
4.1.1 Global Drug Eluting Implant Historical Sales by Type (2016-2021)
4.1.2 Global Drug Eluting Implant Forecasted Sales by Type (2022-2027)
4.1.3 Global Drug Eluting Implant Sales Market Share by Type (2016-2027)
4.2 Global Drug Eluting Implant Revenue by Type
4.2.1 Global Drug Eluting Implant Historical Revenue by Type (2016-2021)
4.2.2 Global Drug Eluting Implant Forecasted Revenue by Type (2022-2027)
4.2.3 Global Drug Eluting Implant Revenue Market Share by Type (2016-2027)
4.3 Global Drug Eluting Implant Price by Type
4.3.1 Global Drug Eluting Implant Price by Type (2016-2021)
4.3.2 Global Drug Eluting Implant Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Drug Eluting Implant Sales by Application
5.1.1 Global Drug Eluting Implant Historical Sales by Application (2016-2021)
5.1.2 Global Drug Eluting Implant Forecasted Sales by Application (2022-2027)
5.1.3 Global Drug Eluting Implant Sales Market Share by Application (2016-2027)
5.2 Global Drug Eluting Implant Revenue by Application
5.2.1 Global Drug Eluting Implant Historical Revenue by Application (2016-2021)
5.2.2 Global Drug Eluting Implant Forecasted Revenue by Application (2022-2027)
5.2.3 Global Drug Eluting Implant Revenue Market Share by Application (2016-2027)
5.3 Global Drug Eluting Implant Price by Application
5.3.1 Global Drug Eluting Implant Price by Application (2016-2021)
5.3.2 Global Drug Eluting Implant Price Forecast by Application (2022-2027)
6 North America
6.1 North America Drug Eluting Implant Market Size by Type
6.1.1 North America Drug Eluting Implant Sales by Type (2016-2027)
6.1.2 North America Drug Eluting Implant Revenue by Type (2016-2027)
6.2 North America Drug Eluting Implant Market Size by Application
6.2.1 North America Drug Eluting Implant Sales by Application (2016-2027)
6.2.2 North America Drug Eluting Implant Revenue by Application (2016-2027)
6.3 North America Drug Eluting Implant Market Size by Country
6.3.1 North America Drug Eluting Implant Sales by Country (2016-2027)
6.3.2 North America Drug Eluting Implant Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug Eluting Implant Market Size by Type
7.1.1 Europe Drug Eluting Implant Sales by Type (2016-2027)
7.1.2 Europe Drug Eluting Implant Revenue by Type (2016-2027)
7.2 Europe Drug Eluting Implant Market Size by Application
7.2.1 Europe Drug Eluting Implant Sales by Application (2016-2027)
7.2.2 Europe Drug Eluting Implant Revenue by Application (2016-2027)
7.3 Europe Drug Eluting Implant Market Size by Country
7.3.1 Europe Drug Eluting Implant Sales by Country (2016-2027)
7.3.2 Europe Drug Eluting Implant Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Eluting Implant Market Size by Type
8.1.1 Asia Pacific Drug Eluting Implant Sales by Type (2016-2027)
8.1.2 Asia Pacific Drug Eluting Implant Revenue by Type (2016-2027)
8.2 Asia Pacific Drug Eluting Implant Market Size by Application
8.2.1 Asia Pacific Drug Eluting Implant Sales by Application (2016-2027)
8.2.2 Asia Pacific Drug Eluting Implant Revenue by Application (2016-2027)
8.3 Asia Pacific Drug Eluting Implant Market Size by Region
8.3.1 Asia Pacific Drug Eluting Implant Sales by Region (2016-2027)
8.3.2 Asia Pacific Drug Eluting Implant Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug Eluting Implant Market Size by Type
9.1.1 Latin America Drug Eluting Implant Sales by Type (2016-2027)
9.1.2 Latin America Drug Eluting Implant Revenue by Type (2016-2027)
9.2 Latin America Drug Eluting Implant Market Size by Application
9.2.1 Latin America Drug Eluting Implant Sales by Application (2016-2027)
9.2.2 Latin America Drug Eluting Implant Revenue by Application (2016-2027)
9.3 Latin America Drug Eluting Implant Market Size by Country
9.3.1 Latin America Drug Eluting Implant Sales by Country (2016-2027)
9.3.2 Latin America Drug Eluting Implant Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drug Eluting Implant Market Size by Type
10.1.1 Middle East and Africa Drug Eluting Implant Sales by Type (2016-2027)
10.1.2 Middle East and Africa Drug Eluting Implant Revenue by Type (2016-2027)
10.2 Middle East and Africa Drug Eluting Implant Market Size by Application
10.2.1 Middle East and Africa Drug Eluting Implant Sales by Application (2016-2027)
10.2.2 Middle East and Africa Drug Eluting Implant Revenue by Application (2016-2027)
10.3 Middle East and Africa Drug Eluting Implant Market Size by Country
10.3.1 Middle East and Africa Drug Eluting Implant Sales by Country (2016-2027)
10.3.2 Middle East and Africa Drug Eluting Implant Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Overview
11.1.3 Boston Scientific Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Boston Scientific Drug Eluting Implant Product Description
11.1.5 Boston Scientific Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Medtronic Drug Eluting Implant Product Description
11.2.5 Medtronic Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Abbott Drug Eluting Implant Product Description
11.3.5 Abbott Recent Developments
11.4 Lepu Medical
11.4.1 Lepu Medical Corporation Information
11.4.2 Lepu Medical Overview
11.4.3 Lepu Medical Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Lepu Medical Drug Eluting Implant Product Description
11.4.5 Lepu Medical Recent Developments
11.5 B. Braun Melsungen
11.5.1 B. Braun Melsungen Corporation Information
11.5.2 B. Braun Melsungen Overview
11.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 B. Braun Melsungen Drug Eluting Implant Product Description
11.5.5 B. Braun Melsungen Recent Developments
11.6 MicroPort Scientific
11.6.1 MicroPort Scientific Corporation Information
11.6.2 MicroPort Scientific Overview
11.6.3 MicroPort Scientific Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 MicroPort Scientific Drug Eluting Implant Product Description
11.6.5 MicroPort Scientific Recent Developments
11.7 Cook Medical
11.7.1 Cook Medical Corporation Information
11.7.2 Cook Medical Overview
11.7.3 Cook Medical Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Cook Medical Drug Eluting Implant Product Description
11.7.5 Cook Medical Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Overview
11.8.3 Terumo Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Terumo Drug Eluting Implant Product Description
11.8.5 Terumo Recent Developments
11.9 Biosensors International
11.9.1 Biosensors International Corporation Information
11.9.2 Biosensors International Overview
11.9.3 Biosensors International Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Biosensors International Drug Eluting Implant Product Description
11.9.5 Biosensors International Recent Developments
11.10 Balton
11.10.1 Balton Corporation Information
11.10.2 Balton Overview
11.10.3 Balton Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Balton Drug Eluting Implant Product Description
11.10.5 Balton Recent Developments
11.11 AlviMedica Medical Technologies
11.11.1 AlviMedica Medical Technologies Corporation Information
11.11.2 AlviMedica Medical Technologies Overview
11.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Description
11.11.5 AlviMedica Medical Technologies Recent Developments
11.12 Biotronik
11.12.1 Biotronik Corporation Information
11.12.2 Biotronik Overview
11.12.3 Biotronik Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Biotronik Drug Eluting Implant Product Description
11.12.5 Biotronik Recent Developments
11.13 Shandong JW Medical
11.13.1 Shandong JW Medical Corporation Information
11.13.2 Shandong JW Medical Overview
11.13.3 Shandong JW Medical Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Shandong JW Medical Drug Eluting Implant Product Description
11.13.5 Shandong JW Medical Recent Developments
11.14 Sino Medical
11.14.1 Sino Medical Corporation Information
11.14.2 Sino Medical Overview
11.14.3 Sino Medical Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Sino Medical Drug Eluting Implant Product Description
11.14.5 Sino Medical Recent Developments
11.15 Beijing AMSINO
11.15.1 Beijing AMSINO Corporation Information
11.15.2 Beijing AMSINO Overview
11.15.3 Beijing AMSINO Drug Eluting Implant Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Beijing AMSINO Drug Eluting Implant Product Description
11.15.5 Beijing AMSINO Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Drug Eluting Implant Value Chain Analysis
12.2 Drug Eluting Implant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Eluting Implant Production Mode & Process
12.4 Drug Eluting Implant Sales and Marketing
12.4.1 Drug Eluting Implant Sales Channels
12.4.2 Drug Eluting Implant Distributors
12.5 Drug Eluting Implant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Eluting Implant Industry Trends
13.2 Drug Eluting Implant Market Drivers
13.3 Drug Eluting Implant Market Challenges
13.4 Drug Eluting Implant Market Restraints
14 Key Findings in The Global Drug Eluting Implant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Drug Eluting Implant Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Rapamycin Eluting Implant
Table 3. Major Manufacturers of Paclitaxel Eluting Implant
Table 4. Major Manufacturers of Everolimus Eluting Implant
Table 5. Major Manufacturers of Others
Table 6. Global Drug Eluting Implant Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Drug Eluting Implant Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Drug Eluting Implant Sales by Region (2016-2021) & (K Units)
Table 9. Global Drug Eluting Implant Sales Market Share by Region (2016-2021)
Table 10. Global Drug Eluting Implant Sales by Region (2022-2027) & (K Units)
Table 11. Global Drug Eluting Implant Sales Market Share by Region (2022-2027)
Table 12. Global Drug Eluting Implant Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Drug Eluting Implant Revenue Market Share by Region (2016-2021)
Table 14. Global Drug Eluting Implant Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Drug Eluting Implant Revenue Market Share by Region (2022-2027)
Table 16. Global Drug Eluting Implant Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Drug Eluting Implant Sales Share by Manufacturers (2016-2021)
Table 18. Global Drug Eluting Implant Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Drug Eluting Implant Revenue Share by Manufacturers (2016-2021)
Table 20. Drug Eluting Implant Price by Manufacturers 2016-2021 (US$/Unit)
Table 21. Global Drug Eluting Implant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Drug Eluting Implant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2020)
Table 23. Drug Eluting Implant Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Drug Eluting Implant Product Offered
Table 25. Date of Manufacturers Enter into Drug Eluting Implant Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 28. Global Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 29. Global Drug Eluting Implant Sales Share by Type (2016-2021)
Table 30. Global Drug Eluting Implant Sales Share by Type (2022-2027)
Table 31. Global Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Drug Eluting Implant Revenue Share by Type (2016-2021)
Table 34. Global Drug Eluting Implant Revenue Share by Type (2022-2027)
Table 35. Drug Eluting Implant Price by Type (2016-2021) & (US$/Unit)
Table 36. Global Drug Eluting Implant Price Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 38. Global Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 39. Global Drug Eluting Implant Sales Share by Application (2016-2021)
Table 40. Global Drug Eluting Implant Sales Share by Application (2022-2027)
Table 41. Global Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Drug Eluting Implant Revenue Share by Application (2016-2021)
Table 44. Global Drug Eluting Implant Revenue Share by Application (2022-2027)
Table 45. Drug Eluting Implant Price by Application (2016-2021) & (US$/Unit)
Table 46. Global Drug Eluting Implant Price Forecast by Application (2022-2027) & (US$/Unit)
Table 47. North America Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 48. North America Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 49. North America Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 52. North America Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 53. North America Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 56. North America Drug Eluting Implant Sales by Country (2022-2027) & (K Units)
Table 57. North America Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Drug Eluting Implant Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 60. Europe Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 61. Europe Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 64. Europe Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 65. Europe Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 68. Europe Drug Eluting Implant Sales by Country (2022-2027) & (K Units)
Table 69. Europe Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Drug Eluting Implant Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 76. Asia Pacific Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 77. Asia Pacific Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Drug Eluting Implant Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Drug Eluting Implant Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Drug Eluting Implant Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Drug Eluting Implant Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 88. Latin America Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 89. Latin America Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Drug Eluting Implant Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Drug Eluting Implant Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Drug Eluting Implant Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Drug Eluting Implant Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Drug Eluting Implant Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Drug Eluting Implant Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Drug Eluting Implant Sales by Application (2016-2021) & (K Units)
Table 100. Middle East and Africa Drug Eluting Implant Sales by Application (2022-2027) & (K Units)
Table 101. Middle East and Africa Drug Eluting Implant Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Drug Eluting Implant Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Drug Eluting Implant Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Drug Eluting Implant Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Drug Eluting Implant Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Drug Eluting Implant Revenue by Country (2022-2027) & (US$ Million)
Table 107. Boston Scientific Corporation Information
Table 108. Boston Scientific Description and Major Businesses
Table 109. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Boston Scientific Drug Eluting Implant Product
Table 111. Boston Scientific Recent Developments
Table 112. Medtronic Corporation Information
Table 113. Medtronic Description and Major Businesses
Table 114. Medtronic Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Medtronic Drug Eluting Implant Product
Table 116. Medtronic Recent Developments
Table 117. Abbott Corporation Information
Table 118. Abbott Description and Major Businesses
Table 119. Abbott Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Abbott Drug Eluting Implant Product
Table 121. Abbott Recent Developments
Table 122. Lepu Medical Corporation Information
Table 123. Lepu Medical Description and Major Businesses
Table 124. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Lepu Medical Drug Eluting Implant Product
Table 126. Lepu Medical Recent Developments
Table 127. B. Braun Melsungen Corporation Information
Table 128. B. Braun Melsungen Description and Major Businesses
Table 129. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. B. Braun Melsungen Drug Eluting Implant Product
Table 131. B. Braun Melsungen Recent Developments
Table 132. MicroPort Scientific Corporation Information
Table 133. MicroPort Scientific Description and Major Businesses
Table 134. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. MicroPort Scientific Drug Eluting Implant Product
Table 136. MicroPort Scientific Recent Developments
Table 137. Cook Medical Corporation Information
Table 138. Cook Medical Description and Major Businesses
Table 139. Cook Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Cook Medical Drug Eluting Implant Product
Table 141. Cook Medical Recent Developments
Table 142. Terumo Corporation Information
Table 143. Terumo Description and Major Businesses
Table 144. Terumo Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Terumo Drug Eluting Implant Product
Table 146. Terumo Recent Developments
Table 147. Biosensors International Corporation Information
Table 148. Biosensors International Description and Major Businesses
Table 149. Biosensors International Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Biosensors International Drug Eluting Implant Product
Table 151. Biosensors International Recent Developments
Table 152. Balton Corporation Information
Table 153. Balton Description and Major Businesses
Table 154. Balton Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Balton Drug Eluting Implant Product
Table 156. Balton Recent Developments
Table 157. AlviMedica Medical Technologies Corporation Information
Table 158. AlviMedica Medical Technologies Description and Major Businesses
Table 159. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. AlviMedica Medical Technologies Drug Eluting Implant Product
Table 161. AlviMedica Medical Technologies Recent Developments
Table 162. Biotronik Corporation Information
Table 163. Biotronik Description and Major Businesses
Table 164. Biotronik Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. Biotronik Drug Eluting Implant Product
Table 166. Biotronik Recent Developments
Table 167. Shandong JW Medical Corporation Information
Table 168. Shandong JW Medical Description and Major Businesses
Table 169. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. Shandong JW Medical Drug Eluting Implant Product
Table 171. Shandong JW Medical Recent Developments
Table 172. Sino Medical Corporation Information
Table 173. Sino Medical Description and Major Businesses
Table 174. Sino Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Sino Medical Drug Eluting Implant Product
Table 176. Sino Medical Recent Developments
Table 177. Beijing AMSINO Corporation Information
Table 178. Beijing AMSINO Description and Major Businesses
Table 179. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Beijing AMSINO Drug Eluting Implant Product
Table 181. Beijing AMSINO Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Drug Eluting Implant Distributors List
Table 185. Drug Eluting Implant Customers List
Table 186. Drug Eluting Implant Market Trends
Table 187. Drug Eluting Implant Market Drivers
Table 188. Drug Eluting Implant Market Challenges
Table 189. Drug Eluting Implant Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Implant Product Picture
Figure 2. Global Drug Eluting Implant Market Share by Type in 2020 & 2027
Figure 3. Rapamycin Eluting Implant Product Picture
Figure 4. Paclitaxel Eluting Implant Product Picture
Figure 5. Everolimus Eluting Implant Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Eluting Implant Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Others
Figure 12. Drug Eluting Implant Report Years Considered
Figure 13. Global Drug Eluting Implant Sales 2016-2027 (K Units)
Figure 14. Global Drug Eluting Implant Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Drug Eluting Implant Revenue 2016-2027 (US$ Million)
Figure 16. Global Drug Eluting Implant Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Drug Eluting Implant Sales Market Share by Region (2016-2021)
Figure 18. Global Drug Eluting Implant Sales Market Share by Region (2022-2027)
Figure 19. North America Drug Eluting Implant Sales YoY (2016-2027) & (K Units)
Figure 20. North America Drug Eluting Implant Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Drug Eluting Implant Sales YoY (2016-2027) & (K Units)
Figure 22. Europe Drug Eluting Implant Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Drug Eluting Implant Sales YoY (2016-2027) & (K Units)
Figure 24. Asia-Pacific Drug Eluting Implant Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Drug Eluting Implant Sales YoY (2016-2027) & (K Units)
Figure 26. Latin America Drug Eluting Implant Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Drug Eluting Implant Sales YoY (2016-2027) & (K Units)
Figure 28. Middle East & Africa Drug Eluting Implant Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Drug Eluting Implant Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Drug Eluting Implant Revenue in 2020
Figure 31. Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 33. Global Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 34. Global Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 35. Global Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 36. North America Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 37. North America Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 38. North America Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 39. North America Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 40. North America Drug Eluting Implant Sales Share by Country (2016-2027)
Figure 41. North America Drug Eluting Implant Revenue Share by Country (2016-2027)
Figure 42. United States Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 45. Europe Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 46. Europe Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 47. Europe Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 48. Europe Drug Eluting Implant Sales Share by Country (2016-2027)
Figure 49. Europe Drug Eluting Implant Revenue Share by Country (2016-2027)
Figure 50. Germany Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 51. France Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Drug Eluting Implant Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Drug Eluting Implant Revenue Share by Region (2016-2027)
Figure 61. China Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 64. India Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 66. China Taiwan Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 71. Latin America Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 73. Latin America Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Drug Eluting Implant Sales Share by Country (2016-2027)
Figure 75. Latin America Drug Eluting Implant Revenue Share by Country (2016-2027)
Figure 76. Mexico Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 79. Colombia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Drug Eluting Implant Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Drug Eluting Implant Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Drug Eluting Implant Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Drug Eluting Implant Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Drug Eluting Implant Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Drug Eluting Implant Revenue Share by Country (2016-2027)
Figure 86. Turkey Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 88. UAE Drug Eluting Implant Revenue (2016-2027) & (US$ Million)
Figure 89. Drug Eluting Implant Value Chain
Figure 90. Drug Eluting Implant Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
世界の薬剤溶出カテーテル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Drug Eluting Catheter Market The global Drug Eluting Catheter market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Drug Eluting Catheter Scope and Segment Drug …- PTCA冠動脈薬剤溶出性バルーンの世界市場 2020年 Market Overview The global PTCA Coronary Drug Eluting Balloons market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The PTCA Coro…
- 薬物溶出バルーンカテーテルの世界市場 2020年 Market Overview The global Drug Eluting Balloon Catheters market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drug Eluting B…
- 世界の防水人工内耳市場インサイト・予測（～2027年） Market Analysis and Insights: Global Waterproof Cochlear Implant Market The global Waterproof Cochlear Implant market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Waterproof Cochlear Implant Scope…
- 世界の防水人工内耳市場インサイト・予測（～2027年） Market Analysis and Insights: Global Waterproof Cochlear Implant Market The global Waterproof Cochlear Implant market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Waterproof Cochlear Implant Scope…